Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2026-03-21 @ 6:51 PM
Study NCT ID:
NCT05283720
Status:
RECRUITING
Last Update Posted:
2025-12-18
First Post:
2022-03-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Sponsor:
Genmab
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
M22-132
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |